|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 413/14 | |
| C07D 403/04 | |||
| C07D 417/14 | |||
| A61K 31/4155 | |||
| A61P 43/00 |
| (11) | Number of the document | 2797915 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12812498.9 |
| Date of filing the European patent application | 2012-12-26 | |
| (97) | Date of publication of the European application | 2014-11-05 |
| (45) | Date of publication and mention of the grant of the patent | 2016-07-13 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2012/071654 |
| Date | 2012-12-26 |
| (87) | Number | WO 2013/101830 |
| Date | 2013-07-04 |
| (30) | Number | Date | Country code |
| 201161580439 P | 2011-12-27 | US | |
| 201261654580 P | 2012-06-01 | US |
| (72) |
KIM, Charles, US
NAKAI, Takashi, US
MOORE, Joel, US
PERL, Nicholas, Robert, US
IM, G-yoon, Jamie, US
BARDEN, Timothy, Claude, US
IYENGAR, Rajesh, R., US
ZIMMER, Daniel, P., US
FRETZEN, Angelika, US
RENHOWE, Paul, Allan, US
|
| (73) |
Ironwood Pharmaceuticals, Inc.,
301 Binney Street, 2nd Floor, Cambridge, MA 02142,
US
|
| (54) | 2-benzyl-3-(oxazole/thiazole)-5-(pyrimidin-2-yl)-1(H)-pyrazole derivatives as stimulators of the soluble guanylate cyclase (sGC) for the treatment of e.g. hypertension or heart failure |
| 2-benzyl-3-(oxazole/thiazole)-5-(pyrimidin-2-yl)-1(H)-pyrazole derivatives as stimulators of the soluble guanylate cyclase (sGC) for the treatment of e.g. hypertension or heart failure |